CSF1R Blockade for Refractory Chronic Graft-versus-Host Disease

被引：3
|
作者：
Mohty, Mohamad [1 ,2 ]
机构：
[1] Sorbonne Univ, Hop St Antoine, Ctr Rech St Antoine, Serv Hematol Clin & Therapie Cellulaire, Paris, France
[2] Hop St Antoine, AP HP, Serv Hematol Clin & Therapie Cellulaire, Paris, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 11期
关键词：
D O I：
10.1056/NEJMe2407369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1055 / 1059
页数：5
相关论文
共 50 条
  • [1] Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease
    Radojcic, Vedran
    Pletneva, Maria
    Lee, Catherine J.
    Ivcevic, Sanja
    Sarantopoulos, Stefanie
    Couriel, Daniel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (02) : E120 - E122
  • [2] Hedgehog blockade in the treatment of steroid-refractory sclerodermatous chronic graft-versus-host disease
    Radojcic, Vedran
    Lee, Catherine
    Pletneva, Maria
    Hicks, Kolleen
    Sarantopoulos, Stefanie
    Couriel, Daniel
    BONE MARROW TRANSPLANTATION, 2019, 54 : 305 - 306
  • [3] Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
    Wolff, Daniel
    Cutler, Corey
    Lee, Stephanie J.
    Pusic, Iskra
    Bittencourt, Henrique
    White, Jennifer
    Hamadani, Mehdi
    Arai, Sally
    Salhotra, Amandeep
    Perez-Simon, Jose A.
    Alousi, Amin
    Choe, Hannah
    Kwon, Mi
    Bermudez, Arancha
    Kim, Inho
    Socie, Gerard
    Chhabra, Saurabh
    Radojcic, Vedran
    O'Toole, Timothy
    Tian, Chuan
    Ordentlich, Peter
    Defilipp, Zachariah
    Kitko, Carrie L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11): : 1002 - 1014
  • [4] Blockade of Chemotaxis in Graft-versus-Host Disease
    Davies, Jeff K.
    Gribben, John G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1667 - 1667
  • [5] How I treat refractory chronic graft-versus-host disease
    Sarantopoulos, Stefanie
    Cardones, Adela R.
    Sullivan, Keith M.
    BLOOD, 2019, 133 (11) : 1191 - 1200
  • [6] Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
    Chin, Michelle
    Shizuru, Judith A.
    Muffly, Lori
    Shiraz, Parveen
    Johnston, Laura J.
    Lowsky, Robert
    Rezvani, Andrew R.
    Frank, Matthew J.
    Bharadwaj, Sushma
    Weng, Wen-Kai
    Negrin, Robert S.
    Miklos, David B.
    Arai, Sally
    BLOOD, 2022, 140 : 4788 - 4789
  • [7] Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
    E Bisaccia
    M Palangio
    J Gonzalez
    K R Adler
    S D Rowley
    S L Goldberg
    Bone Marrow Transplantation, 2003, 31 : 291 - 294
  • [8] Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
    Bisaccia, E
    Palangio, M
    Gonzalez, J
    Adler, KR
    Rowley, SD
    Goldberg, SL
    BONE MARROW TRANSPLANTATION, 2003, 31 (04) : 291 - 294
  • [9] Rituximab for steroid-refractory chronic graft-versus-host disease
    Cutler, Corey
    Miklos, David
    Kim, Haesook T.
    Treister, Nathaniel
    Woo, Sook-Bin
    Bienfang, Don
    Klickstein, Lloyd B.
    Levin, Jesse
    Miller, Katherine
    Reynolds, Carol
    Macdonell, Rebecca
    Pasek, Mildred
    Lee, Stephanie J.
    Ho, Vincent
    Soiffer, Robert
    Antin, Joseph H.
    Ritz, Jerome
    Alyea, Edwin
    BLOOD, 2006, 108 (02) : 756 - 762
  • [10] Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease
    Marcellus, DC
    Altomonte, VL
    Farmer, ER
    Horn, TD
    Freemer, CS
    Grant, J
    Vogelsang, GB
    BLOOD, 1999, 93 (01) : 66 - 70
12345